Shuqiang Yue

1.1k total citations
28 papers, 802 citations indexed

About

Shuqiang Yue is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Shuqiang Yue has authored 28 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 7 papers in Oncology. Recurrent topics in Shuqiang Yue's work include Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (4 papers) and Liver physiology and pathology (3 papers). Shuqiang Yue is often cited by papers focused on Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (4 papers) and Liver physiology and pathology (3 papers). Shuqiang Yue collaborates with scholars based in China and United States. Shuqiang Yue's co-authors include Kefeng Dou, Kaishan Tao, Junjie Li, Zhuochao Zhang, Xiao Li, Jingyue Yang, Meng Pu, Ben Ma, Kefeng Dou and Qike Huang and has published in prestigious journals such as PLoS ONE, Cancer Research and Carbohydrate Polymers.

In The Last Decade

Shuqiang Yue

25 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuqiang Yue China 16 465 265 120 113 105 28 802
Xuguang Hu China 15 379 0.8× 163 0.6× 107 0.9× 156 1.4× 90 0.9× 48 814
Peihao Wen China 14 447 1.0× 261 1.0× 57 0.5× 79 0.7× 64 0.6× 39 749
Xuanfu Xu China 14 470 1.0× 243 0.9× 186 1.6× 75 0.7× 69 0.7× 25 820
Minglu Liang China 20 441 0.9× 185 0.7× 117 1.0× 98 0.9× 118 1.1× 52 884
Feng Ren China 19 721 1.6× 437 1.6× 73 0.6× 79 0.7× 84 0.8× 24 1.1k
Chengyong Tang China 12 319 0.7× 209 0.8× 63 0.5× 84 0.7× 104 1.0× 21 695
Hongfei Tong China 18 392 0.8× 141 0.5× 133 1.1× 84 0.7× 96 0.9× 36 867
Koki Sato Japan 8 489 1.1× 89 0.3× 115 1.0× 85 0.8× 58 0.6× 32 826

Countries citing papers authored by Shuqiang Yue

Since Specialization
Citations

This map shows the geographic impact of Shuqiang Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqiang Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqiang Yue more than expected).

Fields of papers citing papers by Shuqiang Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqiang Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqiang Yue. The network helps show where Shuqiang Yue may publish in the future.

Co-authorship network of co-authors of Shuqiang Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqiang Yue. A scholar is included among the top collaborators of Shuqiang Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqiang Yue. Shuqiang Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoyi, et al.. (2025). Giant Intra-Abdominal Tumor, Compatible with Liposarcoma: A Case Report and Literature Review. American Journal of Case Reports. 26. e948952–e948952.
2.
Tie, Jun, Xulong Yuan, Zhengcai Liu, et al.. (2024). Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results. European Radiology. 35(6). 3256–3261. 2 indexed citations
3.
Wang, Xudan, et al.. (2024). EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167336–167336.
4.
Zhang, Geng, Weijun Qin, Jianlin Yuan, et al.. (2020). A 14-Year Follow-Up of a Combined Liver-Pancreas-Kidney Transplantation: Case Report and Literature Review. Frontiers in Medicine. 7. 148–148. 1 indexed citations
5.
Ye, Yuchen, Junlong Zhao, Chun-Chen Gao, et al.. (2019). NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma. Cancer Research. 79(16). 4160–4172. 82 indexed citations
6.
Liu, Mengmeng, et al.. (2019). Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance. World Journal of Surgical Oncology. 17(1). 163–163. 9 indexed citations
7.
Zhang, Xiao‐Jing, Jing Liu, Kun Liu, Shuqiang Yue, & Kaishan Tao. (2018). Effect of microvascular invasion on prognosis of patients with hepatocellular carcinoma after hepatectomy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(5). 483–487. 1 indexed citations
8.
Zhang, Zhuochao, Xiao Li, Wei Sun, et al.. (2017). Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Letters. 397. 33–42. 245 indexed citations
9.
Zhang, Zhuochao, Xiao Li, Hong Zhang, et al.. (2017). Cytokine profiles in Tibetan macaques following α‐1,3‐galactosyltransferase‐knockout pig liver xenotransplantation. Xenotransplantation. 24(5). 24 indexed citations
10.
Qin, Weijun, Lei Yu, Guosheng Wu, et al.. (2016). Combined Kidney Transplantation and Splenic Fossa Auxiliary Heterotopic Liver Transplantation in a Highly Sensitized Recipient: A Case Report. Transplantation Proceedings. 48(9). 3191–3196. 2 indexed citations
11.
Wang, Zhipeng, Min Shen, Peng Lu, et al.. (2016). NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7. Oncotarget. 8(1). 1714–1724. 21 indexed citations
12.
Ji, Hongchen, Xiao Li, Shuqiang Yue, et al.. (2015). Pig BMSCs Transfected with Human TFPI Combat Species Incompatibility and Regulate the Human TF Pathway in Vitro and in a Rodent Model. Cellular Physiology and Biochemistry. 36(1). 233–249. 27 indexed citations
13.
Yu, Heng‐Chao, Lu Bai, Shuqiang Yue, et al.. (2013). Notch signal protects non-parenchymal cells from ischemia/reperfusion injury in vitro by repressing ROS. Annals of Hepatology. 12(5). 815–821. 27 indexed citations
14.
Shen, Min, Lei Zhao, Rui‐Xin Wu, Shuqiang Yue, & Jianming Pei. (2012). The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms. Vascular Pharmacology. 58(1-2). 64–70. 36 indexed citations
15.
Shen, Min, Rui‐Xin Wu, Lei Zhao, et al.. (2012). Resveratrol Attenuates Ischemia/Reperfusion Injury in Neonatal Cardiomyocytes and Its Underlying Mechanism. PLoS ONE. 7(12). e51223–e51223. 59 indexed citations
16.
Zhao, Wei, Junjie Li, Shuqiang Yue, Linying Zhang, & Kefeng Dou. (2012). Antioxidant activity and hepatoprotective effect of a polysaccharide from Bei Chaihu (Bupleurum chinense DC). Carbohydrate Polymers. 89(2). 448–452. 47 indexed citations
17.
Dou, Kefeng, Desheng Wang, Qingchuan Zhao, et al.. (2010). Liver Transplantation in a Patient with Pulmonary Hypertension at High Altitude. Wilderness and Environmental Medicine. 21(1). 50–53. 1 indexed citations
18.
Cao, Da‐Yong, Jingyue Yang, Shuqiang Yue, et al.. (2009). Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma. Cellular Immunology. 259(1). 13–20. 19 indexed citations
19.
20.
Yue, Shuqiang. (2003). Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis. World Journal of Gastroenterology. 9(12). 2863–2863. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuguang Hu Breakdown of academic impact, for papers by Peihao Wen Breakdown of academic impact, for papers by Xuanfu Xu Breakdown of academic impact, for papers by Minglu Liang Breakdown of academic impact, for papers by Feng Ren Breakdown of academic impact, for papers by Chengyong Tang Breakdown of academic impact, for papers by Hongfei Tong Breakdown of academic impact, for papers by Koki Sato
Rankless by CCL
2026